The FDA determined the data from STARGLO did not provide sufficient evidence to support approving glofitamab-gxbm (Columvi) in combination with gemcitabine and oxaliplatin to treat relapsed/refractory ...

A 23-year-old died after refusing cancer treatment that would most likely have saved her life, an inquest heard.

Cambridge graduate and model Paloma Shemirani died last July after refusing medical assistance for her treatable non-Hodgkin ...

A 23-year-old woman died from cancer after refusing chemotherapy and seeking "alternative" therapies, an inquest has heard.

Hodgkin's lymphoma (HL) is a cancer of the lymphatic system. As part of the immune system, the lymphatic system comprises a network of lymphatic vessels, which transport lymph throughout the body.